CMDA's The Point

Better Science Without the Ideology of Fetal Tissue

January 10, 2019
07192018POINTBLOG NoLogo

by David Prentice, PhD

The debate about use of aborted fetal tissue for research continues, usually characterized as pitting science against ideology. The characterization is accurate, but the stereotypes of who fits in the categories are not. Published science documents the advantages of the numerous NON-fetal tissue research models and techniques, while ideologues claim a continued need for aborted fetal tissue use, by mischaracterizing the science and history, and by ignoring or dismissing outright, modern scientific methods and literature. Indeed, many scientists and medical researchers oppose the use of aborted fetal tissue, yet their voices are rarely heard.

 

Some of the facts were heard publicly in a recent House subcommittee hearing that looked especially at alternatives to fetal tissue. The failures of fetal tissue and the successes of numerous alternatives were extensively documented with abundant literature references. By contrast, the ideology of fetal tissue research makes claims that are often inaccurate and even unscientific. Here are just a few examples.

 

The ideology of fetal tissue research often claims that numerous vaccines were created using aborted fetal tissue. This claim stretches the science to a point of inanity. A few vaccines were initiated in the 1960s and 1970s using two historical cell lines in particular (WI-38 and MRC-5) that were each derived from a single induced abortion, and those historical cell lines still see some limited use for virus growth for a few vaccines. But a cell line is not a tissue. Once cells are established in culture as a cell line (a matter of hours to days), the cells can be propagated in the laboratory for years or even decades, and there is no need to go back and obtain fresh tissue or continually re-initiate the cell line. The derivation source leaves an ethical taint, but the cell lines are not fresh tissue. Thus, saying that polio vaccine was produced in fetal tissue is an unscientific falsehood. By the same token, HeLa cells were also used in the past to make polio vaccine, but it is equally absurd to claim that polio vaccine was produced in human cervical carcinoma tissue. The original Salk and Sabin vaccines were created using monkey tissue.

 

Proponents of the fetal tissue ideology have also claimed other vaccines were developed using aborted fetal tissue, including tetanus and diphtheria. But these are bacterial infections, and such bacterial cells are not grown in human cells or tissues. This falsehood, at one time circulated by the American Society for Cell Biology but then “corrected,” starkly illuminates the unscientific ideological propensity of such claims.

 

Fetal tissue ideology also claims that there are no alternatives to use of fetal tissue to make humanized mice, for study of infectious diseases, drugs against HIV, immunotherapies, etc. These mice are constructed to contain a human immune system by adding human cells and tissues. While in the past many such mice were made using aborted fetal tissue, requiring an ongoing harvest and sourcing of aborted tissue, most humanized mice today are made using umbilical cord blood stem cells, other types of adult stem cells and postnatal tissues. As just one example among several, one type of humanized mouse that supposedly requires aborted fetal thymus can instead be constructed utilizing neonatal thymus removed during pediatric cardiac surgeries. According to the published paper on the technique, use of neonatal thymus produces as complete an immune system as that using aborted fetal thymus, more clinically relevant, and with 50 times as many mice produced per tissue sample. The authors note that when looking at the clinically relevant data, “the NeoThy humanized mouse model is a viable alternative to fetal tissue humanized mice.”

 

As just one other example, the fetal tissue ideology still at times looks to use of fetal tissue to cure diseases. Yet history and the published results have shown repeatedly that fetal tissue has not cured a single condition. Rather, fetal tissue transplants have a history of making patients worse with disastrous side effects. In contrast, adult stem cell transplants have been used to treat well over one million patients for dozens of conditions, including for stroke and multiple sclerosis.

 

Many more examples of the failures of fetal tissue ideology, and the success of numerous modern scientific alternatives, are available. The science and the ethics are on the side of these alternatives, and they point the way to wise use of taxpayer funds that put the patient first.

 

 

 

David Prentice, PhD

About David Prentice, PhD

David A. Prentice is Vice President and Research Director for the Charlotte Lozier Institute. He is also Adjunct Professor of Molecular Genetics at the John Paul II Institute, The Catholic University of America and was a Founding Advisory Board Member for the Midwest Stem Cell Therapy Center, a unique comprehensive stem cell center in Kansas that he was instrumental in creating. In 2020, he was appointed by the Secretary of HHS to the federal Human Fetal Tissue Ethics Advisory Board. Dr. Prentice has over 40 years’ experience as a scientific researcher and professor, including previous service as senior fellow for life sciences at the Family Research Council, Professor of Life Sciences at Indiana State University, and Adjunct Professor of Medical and Molecular Genetics, Indiana University School of Medicine. He established Stem Cell Research Facts, an educational website providing scientific facts and patient-centered videos about adult stem cells, and is a founding member of Do No Harm: The Coalition of Americans for Research Ethics, and an advisory board member for the Center for Bioethics and Human Dignity. He has provided scientific advice for numerous medical professionals, legislators, policymakers and organizations at the state, federal, and international levels. Dr. Prentice received his Ph.D. in biochemistry from the University of Kansas, and was at Los Alamos National Laboratory and the University of Texas Medical School-Houston before joining Indiana State University where in addition to his research and teaching, he served as Acting Associate Dean of Arts and Sciences and Assistant Chair of Life Sciences. He was recognized with the University’s Caleb Mills Distinguished Teaching Award and Faculty Distinguished Service Award. He has taught courses ranging from non-majors biology to advanced and graduate courses including developmental biology, embryology, cell and tissue culture, history of biology, science and politics, pathophysiology, medical genetics, and medical biochemistry. Several of his courses were also taught on-line. He received the 2007 Walter C. Randall Award in Biomedical Ethics from the American Physiological Society, given for promoting the honor and integrity of biomedical science through example and mentoring in the classroom and laboratory. Dr. Prentice’s research interests encompass various aspects of cell growth control, cell and developmental biology; one major focus is adult stem cells. He has reviewed for various professional publications including The Journal of the American Medical Association. He is an internationally-recognized expert on stem cell research, cell biology and bioethics, and has provided scientific lectures and policy briefings in 40 states and 21 countries, including testimony before the U.S. Congress and numerous state legislatures, the U.S. National Academy of Sciences, the President’s Council on Bioethics, European Parliament, British Parliament, Canadian Parliament, Australian Parliament, German Bundestag, French Senate, Swedish Parliament, the United Nations, and the Vatican. He was selected by President George W. Bush’s U.S. President’s Council on Bioethics to write the comprehensive review of adult stem cell research for the Council’s 2004 publication “Monitoring Stem Cell Research.” Dr. Prentice has published numerous scientific and bioethics articles, including a recent review of stem cell science and adult stem cell treatments published in Circulation Research. He has also published numerous commentaries and op-eds, and travels nationally and internationally to give frequent invited lectures regarding stem cell research, fetal tissue research, gene editing, cloning, embryology, cell culture and vaccines, bioethics, and public policy. He has been interviewed in virtually all major electronic and print media outlets, including CNN, ABC, NBC, CBS, Fox, CSPAN, Reuters, AP, NPR, USA Today, BBC, The Washington Post, The Los Angeles Times, and The New York Times.

2 Comments

  1. Andre Van Mol, MD on January 31, 2019 at 10:33 pm

    Outstanding, once again, David. And thank you for all the useful links.



  2. Ken Dormer MS PhD FAHA on February 1, 2019 at 7:03 am

    Hello Dave,
    We met years ago when I invited you to speak at the annual Walter Randall Lectureship in Biomedical Ethics (now discontinued because of complaints against Christianity), part of the Experimental Biology meeting. Thanks brother for serving the Lord these years in science. I just finished a 5 year stint helping start Liberty University’s new med school as Chair of Integrative Physiology and Pharmacology. This issue almost never discusses the Imago Dei concept because the secular science crowd does not recognize the concept and are too focused on the prestige of discovery/publication/career advancement and possible wealth from patented technology.